-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you...
More »SEARCH RESULT
Total Matching Records found : 2545
Aam Aadmi Party declares list of shortlisted candidates for 12 seats-Mohammad Ali
-The Hindu Final list to be decided after consultation with the grass-root workers of the respective areas Taking a lead over all the mainstream political parties, the Aam Aadmi Party on Friday announced its list of 44 shortlisted candidates for 12 constituencies for the Delhi Assembly elections scheduled later this year . The party had invited applications from Delhiites for candidature over a month ago. While releasing the list, AAP convenor Arvind Kejriwal...
More »USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman
-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »Ranbaxy case may take a toll on other Indian drug makers
-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their IMAge may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...
More »Prof. Abhijit Sen, member-Planning Commission interviewed by YogIMA Seth & Madhvi Sally
-The Economic Times The huge delay in bringing the Food Security Bill to Parliament and the massive opposition to it have seen most states going ahead with key provisions of the proposed Bill, Planning Commission member Abhijit Sen tells ET. Sen has doubts whether the bill would be passed in the Monsoon Session of Parliament. Edited excerpts: * Do you think Food Security Bill would be passed in the Monsoon Session? I am not...
More »
